Effects of Release of TSG-6 from Heparin Hydrogels on Supraspinatus Muscle Regeneration

Joseph J Pearson,Jiahui Mao,Johnna S Temenoff

DOI: https://doi.org/10.1101/2024.08.20.608812

2024-08-21

Abstract:Muscle degeneration after rotator cuff tendon tear is a significant clinical problem. In these experiments, we developed a poly(ethylene glycol)-based injectable granular hydrogel containing two heparin derivatives (fully sulfated (Hep) and fully desulfated (Hep-)) as well as a matrix metalloproteinase-sensitive peptide to promote sustained release of Tumor Necrosis Factor Stimulated Gene 6 (TSG-6) over 14+ days in vivo in a rat model of rotator cuff muscle injury. The hydrogel formulations demonstrated similar release profiles in vivo, thus facilitating comparisons between delivery from heparin derivatives on level of tissue repair in two different areas of muscle (near the myotendious junction (MTJ) and in the muscle belly (MB)) that have been shown previously to have differing responses to rotator cuff tendon injury. We hypothesized that sustained delivery of TSG-6 would enhance the anti-inflammatory response following rotator cuff injury through macrophage polarization, and that release from a fully sulfated heparin derivative (Hep) would potentiate this effect throughout the muscle. Inflammatory/immune cells, satellite cells, and fibroadipogenic progenitor cells, were analyzed by flow cytometery 3 and 7 days after injury and hydrogel injection, while metrics of muscle healing were examined via immunohistochemistry up to Day 14. Results showed controlled delivery of TSG-6 from Hep caused heightened macrophage response (Day 14 macrophages, 4.00 +- 1.85% single cells, M2a, 3.27 +- 1.95% single cells) and increased markers of early muscle regeneration (embryonic heavy chain staining) by Day 7, particularly in the MTJ region of the muscle, compared to release from desulfated heparin hydrogels. This work provides a novel strategy for localized, controlled delivery of TSG-6 to enhance muscle healing after rotator cuff tear.

Bioengineering

What problem does this paper attempt to address?

The problem this paper attempts to address is muscle degeneration following rotator cuff tendon tears. Specifically, the researchers developed an injectable particulate hydrogel system based on polyethylene glycol (PEG), which contains two heparin derivatives (fully sulfated heparin (Hep) and fully desulfated heparin (Hep-)), as well as a matrix metalloproteinase-sensitive peptide, to promote the sustained release of tumor necrosis factor-stimulated gene 6 (TSG-6) for more than 14 days in a rat rotator cuff muscle injury model.

The primary objective of the study is to enhance the anti-inflammatory response following rotator cuff injury through the sustained release of TSG-6, particularly via macrophage polarization, and it is hypothesized that the release of TSG-6 from fully sulfated heparin derivatives (Hep) will enhance this effect. Additionally, the study aims to compare the different responses of various muscle regions (near the myotendinous junction (MTJ) and the muscle belly (MB)) to rotator cuff tendon injury, as these regions have previously been shown to respond differently to rotator cuff tendon injuries.